Master Techniques in Upper and Lower Airway Management
Authors:
- Velly Lionel JVJVelly Lionel J
- Bilotta FedericoBFBilotta Federico
- Fàbregas NeusFNFàbregas Neus
- Soehle MartinSMSoehle Martin
- Bruder Nicolas JBJBruder Nicolas J
- Nathanson Michael HNHNathanson Michael H
- Null NullNNNull Null
- 1 November 2015
- journal article
- book review
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 32 (11) , 824-176
Abstract
Many aspects of the perioperative management of aneurysmal subarachnoid haemorrhage (SAH) remain controversial. It would be useful to assess differences in the treatment of SAH in Europe to identify areas for improvement.To determine the clinical practice of physicians treating SAH and to evaluate any discrepancy between practice and published evidence.An electronic survey.Physicians identified through each national society of neuroanaesthesiology and neurocritical care.A 31-item online questionnaire was distributed by the ENIG group. Questions were designed to investigate anaesthetic management of SAH and diagnostic and treatment approaches to cerebral vasospasm. The survey was available from early October to the end of November 2012.Completed surveys were received from 268 respondents, of whom 81% replied that aneurysm treatment was conducted early (within 24 h). Sixty-five percent of centres treated more than 60% of SAH by coiling, 19% had high-volume clipping (>60% of aneurysms clipped) and 16% used both methods equally. No clear threshold for arterial blood pressure target was identified during coiling, temporary clipping or in patients without vasospasm after the aneurysm had been secured. Almost all respondents used nimodipine (97%); 21% also used statins and 20% used magnesium for prevention of vasospasm. A quarter of respondents used intra-arterial vasodilators alone, 5% used cerebral angioplasty alone and 48% used both endovascular methods to treat symptomatic vasospasm. In high-volume clipping treatment centres, 58% of respondents used endovascular methods to manage vasospasm compared with 86% at high-volume coiling treatment centres (P < 0.001). The most commonly used intra-arterial vasodilator was nimodipine (82%), but milrinone was used by 23% and papaverine by 19%. More respondents (44%) selected 'triple-H' therapy over hypertension alone (30%) to treat vasospasm.We found striking variability in the practice patterns of European physicians involved in early treatment of SAH. Significant differences were noted among countries and between high and low-volume coiling centres.Keywords
This publication has 27 references indexed in Scilit:
- European Stroke Organization Guidelines for the Management of Intracranial Aneurysms and Subarachnoid HaemorrhageCerebrovascular Diseases, 2013
- Critical Care Management of Patients Following Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus ConferenceNeurocritical Care, 2011
- Critical care and the global burden of critical illness in adultsThe Lancet, 2010
- Intensive care of aneurysmal subarachnoid hemorrhage: an international surveyIntensive Care Medicine, 2009
- Guidelines for the Management of Aneurysmal Subarachnoid HemorrhageStroke, 2009
- A guide for the design and conduct of self-administered surveys of cliniciansCanadian Medical Association Journal, 2008
- Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trendsJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Impact of Hospital-Related Factors on Outcome After Treatment of Cerebral AneurysmsStroke, 2003
- Case-Fatality Rates and Functional Outcome After Subarachnoid HemorrhageStroke, 1997
- Cooperative Study of Intracranial Aneurysms and Subarachnoid Hemorrhage: A Long-term Prognostic StudyArchives of Neurology, 1984